LP220257-2
Etanercept
Active
Description
Etanercept (tradename Enbrel) is a biopharmaceutical fusion protein used alone or with other medications to relieve the symptoms of autoimmune disorders including: rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis (JIA), ankylosing spondylitis, Crohn's disease and refractory asthma. Etanercept is a tumor-necrosis factor (TNF) inhibitor, and works by blocking the action of the protein TNF-alpha, which is a proinflammatory cytokine. Common side effects are headache; pain, redness, itching, or swelling around the injection site; stuffy or runny nose; throat irritation. Source: Regenstrief LOINC, MedlinePlus: Etanercept Injection
Basic Part Properties
- Part Name
- Etanercept
- Part Display Name
- Etanercept
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-06-24
- Construct for LOINC Short Name
- Etanercept
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 依那西普 Synonyms: Enbrel; |
| es-ES | Spanish (Spain) | Etarnecep |
| it-IT | Italian (Italy) | Etanercept |
| fr-FR | French (France) | Etanercept |
| pl-PL | Polish (Poland) | Etanercept |
| nl-NL | Dutch (Netherlands) | etanercept |
| el-GR | Greek (Greece) | Ετανερσέπτη Synonyms: Ετανερσέπτη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://